KYOCY Quote, Financials, Valuation and Earnings

Kubota has a net margin of -3.6% compared to Kyocera's net margin of 6.75%. Kyocera's return on equity of 1.45% beat Kubota's return on equity of 9.86%.

Kyocera has a consensus price target of $11.40, signalling downside risk potential of --. On the other hand Kubota has an analysts' consensus of -- which suggests that it could grow by 30.35%. Given that Kubota has higher upside potential than Kyocera, analysts believe Kubota is more attractive than Kyocera.

Kyocera has a beta of 0.241, which suggesting that the stock is 75.921% less volatile than S&P 500. In comparison Kubota has a beta of 0.963, suggesting its less volatile than the S&P 500 by 3.749%.

Kyocera has a quarterly dividend of $0.17 per share corresponding to a yield of 2.82%. Kubota offers a yield of 2.64% to investors and pays a quarterly dividend of $0.82 per share. Kyocera pays 73.91% of its earnings as a dividend. Kubota pays out 24.99% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Kyocera quarterly revenues are $3.2B, which are smaller than Kubota quarterly revenues of $4.7B. Kyocera's net income of -$116.4M is lower than Kubota's net income of $317.2M. Notably, Kyocera's price-to-earnings ratio is 50.63x while Kubota's PE ratio is 8.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kyocera is 1.18x versus 0.73x for Kubota. Usually stocks with elevated PS ratios are considered overvalued.

SBC Medical Group Holdings has a net margin of -3.6% compared to Kyocera's net margin of 5.34%. Kyocera's return on equity of 1.45% beat SBC Medical Group Holdings's return on equity of 25.89%.

Kyocera has a consensus price target of $11.40, signalling downside risk potential of --. On the other hand SBC Medical Group Holdings has an analysts' consensus of $10.00 which suggests that it could grow by 207.69%. Given that SBC Medical Group Holdings has higher upside potential than Kyocera, analysts believe SBC Medical Group Holdings is more attractive than Kyocera.

Kyocera has a beta of 0.241, which suggesting that the stock is 75.921% less volatile than S&P 500. In comparison SBC Medical Group Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Kyocera has a quarterly dividend of $0.17 per share corresponding to a yield of 2.82%. SBC Medical Group Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kyocera pays 73.91% of its earnings as a dividend. SBC Medical Group Holdings pays out -- of its earnings as a dividend. Kyocera's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Kyocera quarterly revenues are $3.2B, which are larger than SBC Medical Group Holdings quarterly revenues of $53.1M. Kyocera's net income of -$116.4M is lower than SBC Medical Group Holdings's net income of $2.8M. Notably, Kyocera's price-to-earnings ratio is 50.63x while SBC Medical Group Holdings's PE ratio is 7.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kyocera is 1.18x versus 1.50x for SBC Medical Group Holdings. Usually stocks with elevated PS ratios are considered overvalued.

SECOM has a net margin of -3.6% compared to Kyocera's net margin of 9.53%. Kyocera's return on equity of 1.45% beat SECOM's return on equity of 7.56%.

Kyocera has a consensus price target of $11.40, signalling downside risk potential of --. On the other hand SECOM has an analysts' consensus of -- which suggests that it could fall by --. Given that Kyocera has higher upside potential than SECOM, analysts believe Kyocera is more attractive than SECOM.

Kyocera has a beta of 0.241, which suggesting that the stock is 75.921% less volatile than S&P 500. In comparison SECOM has a beta of 0.351, suggesting its less volatile than the S&P 500 by 64.883%.

Kyocera has a quarterly dividend of $0.17 per share corresponding to a yield of 2.82%. SECOM offers a yield of 1.75% to investors and pays a quarterly dividend of $0.08 per share. Kyocera pays 73.91% of its earnings as a dividend. SECOM pays out 39.71% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Kyocera quarterly revenues are $3.2B, which are larger than SECOM quarterly revenues of $2B. Kyocera's net income of -$116.4M is lower than SECOM's net income of $190.3M. Notably, Kyocera's price-to-earnings ratio is 50.63x while SECOM's PE ratio is 20.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kyocera is 1.18x versus 2.74x for SECOM. Usually stocks with elevated PS ratios are considered overvalued.

THK has a net margin of -3.6% compared to Kyocera's net margin of 2.32%. Kyocera's return on equity of 1.45% beat THK's return on equity of 3.53%.

Kyocera has a consensus price target of $11.40, signalling downside risk potential of --. On the other hand THK has an analysts' consensus of -- which suggests that it could fall by --. Given that Kyocera has higher upside potential than THK, analysts believe Kyocera is more attractive than THK.

Kyocera has a beta of 0.241, which suggesting that the stock is 75.921% less volatile than S&P 500. In comparison THK has a beta of 0.865, suggesting its less volatile than the S&P 500 by 13.478%.

Kyocera has a quarterly dividend of $0.17 per share corresponding to a yield of 2.82%. THK offers a yield of 0.93% to investors and pays a quarterly dividend of $0.06 per share. Kyocera pays 73.91% of its earnings as a dividend. THK pays out 39.92% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Kyocera quarterly revenues are $3.2B, which are larger than THK quarterly revenues of $574.1M. Kyocera's net income of -$116.4M is lower than THK's net income of $13.3M. Notably, Kyocera's price-to-earnings ratio is 50.63x while THK's PE ratio is 35.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kyocera is 1.18x versus 1.33x for THK. Usually stocks with elevated PS ratios are considered overvalued.